Product Comparison
![]() |
![]() |
![]() |
![]() |
![]() |
|
---|---|---|---|---|---|
McKesson # | 916327 | 1182022 | 1031503 | 1043593 | 1043595 |
Description | Digoxin 0.25 mg / mL Injection 2 mL | Digoxin 0.25 mg / mL Injection 2 mL | Digoxin 0.125 mg Tablet 100 Tablets | Digoxin 0.125 mg Tablet 100 Tablets | Digoxin 0.25 mg Tablet 100 Tablets |
Manufacturer # | 00641141035 | 1015080 | 00904592161 | 16714059001 | 16714059101 |
Brand | |||||
Manufacturer | Hikma Pharmaceuticals USA | Healthfirst | Major Pharmaceuticals | NorthStar Rx | NorthStar Rx |
Invoice | DIGOXIN, AMP 500MCG 2ML (25/CT) | DIGOXIN, AMP 250MCG/ML 2ML | DIGOXIN, TAB 125MCG UD (100/BX) | DIGOXIN, TAB 0.125MG (100/BT) RX | DIGOXIN, TAB 0.250MG (100/BT) RX |
Log In to Order | Log In to Order | Log In to Order | Log In to Order | Log In to Order | |
Comparison |
|||||
Alternate Manufacturer Number | 1878370 | 1843630 | 3559192 | 3559226 | |
Alternate Packaging | EA/1 | ||||
Container Type | Ampule | Ampule | Blister Pack | Bottle | Bottle |
Country of Origin | Unknown | Portugal | Unknown | Unknown | Unknown |
Dosage Form | Injection | Injection | Tablet | Tablet | Tablet |
Generic Drug Code | 00101 | 00101 | 00132 | 00132 | 00133 |
NDC Number | 00641141035 | 51662121703 | 00904592161 | 16714059001 | 16714059101 |
Quantity | 100 Tablets | 100 Tablets | 100 Tablets | ||
Strength | 0.25 mg / mL | 0.25 mg / mL | 0.125 mg | 0.125 mg | 0.25 mg |
Type | Unit Dose | ||||
Volume | 2 mL | 2 mL | |||
Application | Cardiotonic Agent | Cardiotonic Agent | Cardiotonic Agent | Cardiotonic Agent | Cardiotonic Agent |
Generic Drug Name | Digoxin | Digoxin | Digoxin | Digoxin | Digoxin |
Product Dating | McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days |
UNSPSC Code | 51124404 | 51124404 | 51124404 | 51124404 | 51124404 |
Features and Benefits |
|
|
|
|
|